(Health) Bionovo's Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression And Cell Type Specificity
Bionovo, Inc. (Nasdaq: BNVI) announced that a study of the gene regulation in multiple cell lines by several of their estrogen receptor beta (ERb) candidates will be published in Public Library of Science One. "In this study we show that plant-derived ERb compounds are as selective as synthetic compounds, but regulate different genes.
Read more ...
Tags (health, health issue, health news, health care, medicine, medical innovation, health problem)
Posted in: on Thursday, July 23, 2009 at at 10:12 AM
